Search the DDRCCs
Enrichment Activities
2012
Diversity and specificity of the mitogen-activated protein kinase phosphatase-1 functions. Lawan A, Shi H, Gatzke F, Bennett AM Cellular and molecular life sciences : CMLS, 2012 Jun 14, (2012)
2011
Peroxisome proliferation-associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity. Diano S, Liu Z-W, Jeong JK, Dietrich MO, Ruan H-B, Kim E, Suyama S, Kelly K, Gyengesi E, Arbiser JL, Belsham DD, Sarruf DA, Schwartz MW, Bennett AM, Shanabrough M, et al. Nature medicine, 2011 Sep, Volume 17, Issue 9, p.1121-7, (2011)
Loss of mitogen-activated protein kinase phosphatase-1 protects from hepatic steatosis by repression of cell death-inducing DNA fragmentation factor A (DFFA)-like effector C (CIDEC)/fat-specific protein 27. Flach RRJ, Qin H, Zhang L, Bennett AM The Journal of biological chemistry, 2011 Jun 24, Volume 286, Issue 25, p.22195-202, (2011)
2010
Mitogen-activated protein kinase phosphatase-1 - a potential therapeutic target in metabolic disease. Roth Flach RJ, Bennett AM Expert opinion on therapeutic targets, 2010 Dec, Volume 14, Issue 12, p.1323-32, (2010)
MAP kinase phosphatase-1 deficiency impairs skeletal muscle regeneration and exacerbates muscular dystrophy. Shi H, Boadu E, Mercan F, Le AM, Flach RRJ, Zhang L, Tyner KJ, Olwin BB, Bennett AM FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2010 Aug, Volume 24, Issue 8, p.2985-97, (2010)
Analysis of protein tyrosine phosphatases and substrates. Mercan F, Bennett AM Current protocols in molecular biology / edited by Frederick M. Ausubel ... [et al.], 2010 Jul, Volume Chapter 18, p.Unit 18.16, (2010)
MAP kinase phosphatase-1--a new player at the nexus between sarcopenia and metabolic disease. Flach RRJ, Bennett AM Aging, 2010 Mar, Volume 2, Issue 3, p.170-6, (2010)
2013
Diversity and specificity of the mitogen-activated protein kinase phosphatase-1 functions. Lawan A, Shi H, Gatzke F, Bennett AM Cellular and molecular life sciences : CMLS, 2013 Jan, Volume 70, Issue 2, p.223-37, (2013)
2010
Mitogen-activated protein kinase phosphatase-1 - a potential therapeutic target in metabolic disease. Roth Flach RJ, Bennett AM Expert opinion on therapeutic targets, 2010 Dec, Volume 14, Issue 12, p.1323-32, (2010)
MAP kinase phosphatase-1--a new player at the nexus between sarcopenia and metabolic disease. Flach RRJ, Bennett AM Aging, 2010 Mar, Volume 2, Issue 3, p.170-6, (2010)
2013
Improved regenerative myogenesis and muscular dystrophy in mice lacking Mkp5. Shi H, Verma M, Zhang L, Dong C, Flavell RA, Bennett AM The Journal of clinical investigation, 2013 May 1, Volume 123, Issue 5, p.2064-77, (2013)
Receptor protein tyrosine phosphatase-receptor tyrosine kinase substrate screen identifies EphA2 as a target for LAR in cell migration. Lee H, Bennett AM Molecular and cellular biology, 2013 Apr, Volume 33, Issue 7, p.1430-41, (2013)
Novel role for SHP-2 in nutrient-responsive control of S6 kinase 1 signaling. Mercan F, Lee H, Kolli S, Bennett AM Molecular and cellular biology, 2013 Jan, Volume 33, Issue 2, p.293-306, (2013)